Discuss This Drug

LEVERTIRACETAM

CHEBI:CHEBI_752028

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
387003
product_type
HUMAN PRESCRIPTION DRUG
route
ORAL
marketing_category
ANDA
listing_expiration_date
20241231
nui
N0000008486
pharm_class_pe
Decreased Central Nervous System Disorganized Electrical Activity [PE]
pharm_class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
dosage_form
TABLET, FILM COATED
active_ingredient_strength
1000 mg/1
active_ingredient_name
LEVETIRACETAM
unii
44YRR34555
marketing_start_date
20190603
package_marketing_start_date
20190603
labeler_name
Direct_Rx
manufacturer_name
Direct_Rx
application_number
ANDA078993
generic_name
LEVERTIRACETAM
brand_name
LEVERTIRACETAM
brand_name_base
LEVERTIRACETAM
product_ndc
61919-830
spl_id
8a719215-d0d5-42fb-e053-2a95a90a60da
package_ndc
61919-830-60
package_description
60 TABLET, FILM COATED in 1 BOTTLE (61919-830-60)
spl_set_id
8a719215-d0d4-42fb-e053-2a95a90a60da
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class